Cargando…

The role of vimentin in the tumor marker Nup88-dependent multinucleated phenotype

BACKGROUND: Nucleoporin Nup88, a component of nuclear pore complexes, is known to be overexpressed in several types of tumor tissue. The overexpression of Nup88 has been reported to promote the early step of tumorigenesis by inducing multinuclei in both HeLa cells and a mouse model. However, the mol...

Descripción completa

Detalles Bibliográficos
Autores principales: Makise, Masaki, Nakamura, Hideaki, Kuniyasu, Akihiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5934895/
https://www.ncbi.nlm.nih.gov/pubmed/29724197
http://dx.doi.org/10.1186/s12885-018-4454-y
_version_ 1783320202877861888
author Makise, Masaki
Nakamura, Hideaki
Kuniyasu, Akihiko
author_facet Makise, Masaki
Nakamura, Hideaki
Kuniyasu, Akihiko
author_sort Makise, Masaki
collection PubMed
description BACKGROUND: Nucleoporin Nup88, a component of nuclear pore complexes, is known to be overexpressed in several types of tumor tissue. The overexpression of Nup88 has been reported to promote the early step of tumorigenesis by inducing multinuclei in both HeLa cells and a mouse model. However, the molecular basis of how Nup88 leads to a multinucleated phenotype remains unclear because of a lack of information concerning its binding partners. In this study, we characterize a novel interaction between Nup88 and vimentin. We also examine the involvement of vimentin in the Nup88-dependent multinucleated phenotype. METHODS: Cells overexpressing tagged versions of Nup88, vimentin and their truncations were used in this study. Coprecipitation and GST-pulldown assays were carried out to analyze protein-protein interactions. Vimentin knockdown by siRNA was performed to examine the functional role of the Nup88-vimentin interaction in cells. The phosphorylation status of vimentin was analyzed by immunoblotting using an antibody specific for its phosphorylation site. RESULTS: Vimentin was identified as a Nup88 interacting partner, although it did not bind to other nucleoporins, such as Nup50, Nup214, and Nup358, in HeLa cell lysates. The N-terminal 541 amino acid residues of Nup88 was found to be responsible for its interaction with vimentin. Recombinant GST-tagged Nup88 bound to recombinant vimentin in a GST-pulldown assay. Although overexpression of Nup88 in HeLa cells was observed mainly at the nuclear rim and in the cytoplasm, colocalization with vimentin was only partially detected at or around the nuclear rim. Disruption of the Nup88-vimentin interaction by vimentin specific siRNA transfection suppressed the Nup88-dependent multinucleated phenotype. An excess amount of Nup88 in cell lysates inhibited the dephosphorylation of a serine residue (Ser83) within the vimentin N-terminal region even in the absence and presence of an exogenous phosphatase. The N-terminal 96 amino acid residues of vimentin interacted with both full-length and the N-terminal 541 residues of Nup88. CONCLUSIONS: Nup88 can affect the phosphorylation status of vimentin, which may contribute to the Nup88-dependent multinucleated phenotype through changing the organization of vimentin.
format Online
Article
Text
id pubmed-5934895
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-59348952018-05-11 The role of vimentin in the tumor marker Nup88-dependent multinucleated phenotype Makise, Masaki Nakamura, Hideaki Kuniyasu, Akihiko BMC Cancer Research Article BACKGROUND: Nucleoporin Nup88, a component of nuclear pore complexes, is known to be overexpressed in several types of tumor tissue. The overexpression of Nup88 has been reported to promote the early step of tumorigenesis by inducing multinuclei in both HeLa cells and a mouse model. However, the molecular basis of how Nup88 leads to a multinucleated phenotype remains unclear because of a lack of information concerning its binding partners. In this study, we characterize a novel interaction between Nup88 and vimentin. We also examine the involvement of vimentin in the Nup88-dependent multinucleated phenotype. METHODS: Cells overexpressing tagged versions of Nup88, vimentin and their truncations were used in this study. Coprecipitation and GST-pulldown assays were carried out to analyze protein-protein interactions. Vimentin knockdown by siRNA was performed to examine the functional role of the Nup88-vimentin interaction in cells. The phosphorylation status of vimentin was analyzed by immunoblotting using an antibody specific for its phosphorylation site. RESULTS: Vimentin was identified as a Nup88 interacting partner, although it did not bind to other nucleoporins, such as Nup50, Nup214, and Nup358, in HeLa cell lysates. The N-terminal 541 amino acid residues of Nup88 was found to be responsible for its interaction with vimentin. Recombinant GST-tagged Nup88 bound to recombinant vimentin in a GST-pulldown assay. Although overexpression of Nup88 in HeLa cells was observed mainly at the nuclear rim and in the cytoplasm, colocalization with vimentin was only partially detected at or around the nuclear rim. Disruption of the Nup88-vimentin interaction by vimentin specific siRNA transfection suppressed the Nup88-dependent multinucleated phenotype. An excess amount of Nup88 in cell lysates inhibited the dephosphorylation of a serine residue (Ser83) within the vimentin N-terminal region even in the absence and presence of an exogenous phosphatase. The N-terminal 96 amino acid residues of vimentin interacted with both full-length and the N-terminal 541 residues of Nup88. CONCLUSIONS: Nup88 can affect the phosphorylation status of vimentin, which may contribute to the Nup88-dependent multinucleated phenotype through changing the organization of vimentin. BioMed Central 2018-05-03 /pmc/articles/PMC5934895/ /pubmed/29724197 http://dx.doi.org/10.1186/s12885-018-4454-y Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Makise, Masaki
Nakamura, Hideaki
Kuniyasu, Akihiko
The role of vimentin in the tumor marker Nup88-dependent multinucleated phenotype
title The role of vimentin in the tumor marker Nup88-dependent multinucleated phenotype
title_full The role of vimentin in the tumor marker Nup88-dependent multinucleated phenotype
title_fullStr The role of vimentin in the tumor marker Nup88-dependent multinucleated phenotype
title_full_unstemmed The role of vimentin in the tumor marker Nup88-dependent multinucleated phenotype
title_short The role of vimentin in the tumor marker Nup88-dependent multinucleated phenotype
title_sort role of vimentin in the tumor marker nup88-dependent multinucleated phenotype
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5934895/
https://www.ncbi.nlm.nih.gov/pubmed/29724197
http://dx.doi.org/10.1186/s12885-018-4454-y
work_keys_str_mv AT makisemasaki theroleofvimentininthetumormarkernup88dependentmultinucleatedphenotype
AT nakamurahideaki theroleofvimentininthetumormarkernup88dependentmultinucleatedphenotype
AT kuniyasuakihiko theroleofvimentininthetumormarkernup88dependentmultinucleatedphenotype
AT makisemasaki roleofvimentininthetumormarkernup88dependentmultinucleatedphenotype
AT nakamurahideaki roleofvimentininthetumormarkernup88dependentmultinucleatedphenotype
AT kuniyasuakihiko roleofvimentininthetumormarkernup88dependentmultinucleatedphenotype